Spectral CT-based quantitative analysis of iodine content for differentiating angiomyolipoma with minimal fat and clear cell renal cell carcinoma

Jinghong Liu,Ailian Liu,Shifeng Tian,Heqing Wang,Chunmei Ma,Ye Ju,Bo Sun
2013-01-01
Abstract:Objective: To evaluate the differential diagnostic value of iodine content based spectral CT for renal angiomyolipoma (AML) with minimal fat and clear cell renal cell carcinoma (CCRCC). Methods: Twenty-seven patients with small solid renal masses, including 20 cases of CCRCC and 7 cases of renal AML with minimal fat confirmed with pathology were scanned with spectral CT. The diameter of each tumor was not more than 3 cm. All patients underwent three-phase enhance spectral CT imaging using GE Discovery CT750 HD, the iodine-based material decomposition images were reconstructed with gemstone imaging Viewer, and absolute and normalized iodine concentrations for renal lesions were obtained. All results were analyzed statistically with independent-samples t test. The diagnostic performances were evaluated using ROC analysis. Results: Normalized iodine concentrations of CCRCC were higher than that of renal AML with minimal fat in all three phases (P<0.05). According to ROC, area under curve of normalized iodine concentration was 0.779, 0.943 and 0.900 in the cortex phase, corticomedullary phase and equilibrium phase, respectively. Taking normalized iodine concentration 42.98 (100 μg/cm3), 68.01 (100 μg/cm3) and 72.09 (100 μg/cm3) as threshold values of the cortex phase, corticomedullary phase and equilibrium phase, the sensitivity and specificity was 55.0% and 100%, 85.0% and 100%, 75.0% and 85.7%, respectively. Conclusion: Taking normalized iodine concentration 68.01 (100 μg/cm3) as threshold value in the corticomedullary phase can help to differential diagnosis of CCRCC and renal AML with minimal fat. Copyright © 2013 by the Press of Chinese Journal of Medical Imaging Technology.
What problem does this paper attempt to address?